Impact of deintensifying hypoglycaemic drugs in older adults with type 2 diabetes: protocol for an emulation of a target trial

Nov-23

AUTHORS : Dr Antoine Christiaens, Clinical Pharmacy Research Group, Lourvain Drug Research, Université catholique de Louvain, Brussels, Belgium. Email: antoine.christiaens@uclouvain.be

JOURNAL : BMJ Journals

REFERENCE: 2023-073081

DOI : 10.1136/ bmjopen-2023-073081

Impact of deintensifying hypoglycaemic drugs in older adults with type 2 diabetes: protocol for an emulation of a target trial

More publications

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Increased risk of fracture among patients with iron overload: a population-based matched cohort study